Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2003-07-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0006-291X(03)01190-2PMID 12859967
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Psoriasin interacts with Jab1 and influences breast cancer progression.

  2003cited by this paper
• Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer

  2002cited by this paper
• Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.

  2002cited by this paper
• Expression of S100A6 and S100A4 in Matched Samples of Human Colorectal Mucosa, Primary Colorectal Adenocarcinomas and Liver Metastases

  2002cited by this paper
• RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease

  2002cited by this paper
• S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes

  2002cited by this paper
• S100 proteins: structure, functions and pathology.

  2002cited by this paper
• Protein S100A4: too long overlooked by pathologists?

  2002cited by this paper
• S100β Interaction with Tau Is Promoted by Zinc and Inhibited by Hyperphosphorylation in Alzheimer's Disease

  2001cited by this paper
• Quantitative cell dispersion analysis: New test to measure tumor cell aggressiveness

  2001cited by this paper
• Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells

  2001cited by this paper
• Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

  2001cited by this paper
• S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease.

  2001cited by this paper
• Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations

  2001cited by this paper
• Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins.

  2001cited by this paper
• S100A2, a Putative Tumor Suppressor Gene, Regulates In Vitro Squamous Cell Carcinoma Migration

  2001cited by this paper
• Proinflammatory properties of the human S100 protein S100A12

  2001cited by this paper
• Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma.

  2001cited by this paper
• S100A1, a new marker for acute myocardial ischemia.

  2000cited by this paper
• Identification of MRP‐8 (calgranulin A) as a major responsive protein in chronic periodontitis

  2000cited by this paper
• Multiple tissue core arrays in histopathology research: a validation study

  2000cited by this paper
• Validation of Tissue Microarray Technology in Breast Carcinoma

  2000cited by this paper
• Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients witholorectal adenocarcinoma

  2000cited by this paper
• beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1.

  2000cited by this paper
• Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.

  2000cited by this paper
• Coregulation of Neurite Outgrowth and Cell Survival by Amphoterin and S100 Proteins through Receptor for Advanced Glycation End Products (RAGE) Activation*

  2000cited by this paper
• Comparison of the metastasis‐inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer

  2000cited by this paper
• Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma

  1999cited by this paper
• Supratentorial Pilocytic Astrocytomas, Astrocytomas, Anaplastic Astrocytomas and Glioblastomas are Characterized by a Differential Expression of S100 Proteins

  1999cited by this paper
• Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy

  1999cited by this paper
• RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

  1999cited by this paper
• S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.

  1999cited by this paper
• The identification and differential expression of calcium-binding proteins associated with ocular melanoma.

  1998cited by this paper
• Calcium-binding protein S100A4 in health and disease.

  1998cited by this paper
• Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

  1998cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper
• Differential expression patterns of S100a2, S100a4 and S100a6 during progression of human malignant melanoma

  1997cited by this paper
• Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions

  1997cited by this paper
• Preneoplasia-associated expression of calcyclin and of binding sites for synthetic blood group A/H trisaccharide--exposing neoglycoconjugates in human lung.

  1997cited by this paper
• Expression pattern of S100 calcium‐binding proteins in human tumors

  1996cited by this paper
• Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family.

  1995cited by this paper
• Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases.

  1994cited by this paper
• Metastasis-Associated mts1 Gene Expression Correlates with Increased p53 Detection in the B16 Murine Melanoma

  1994cited by this paper
• Metastasis associated MTS1 and NM23 genes affect tubulin polymerisation in B16 melanomas: a possible mechanism of their regulation of metastatic behaviour of tumours.

  1993cited by this paper
• Malignant teratoma of the lung with lymph node metastasis of the ectodermal compartment: a case report.

  1993cited by this paper
• Blockade of RAGE ± amphoterin signalling suppresses tumour growth and metastases

  year unknowncited by this paper

• A hybrid protein is a functional molecule to reduce the cytokine storm caused by excessively activated macrophages

  2025influential citation
• A review on clinical implications of S100 proteins in lung diseases

  2025cites this paper
• S100A8/A9 innate immune signaling as a distinct mechanism driving progression of smoking-related breast cancers

  2025cites this paper
• Antimicrobial Peptide Signaling in Skin Diseases

  2025cites this paper
• Pre‐diagnostic plasma advanced glycation end‐products and soluble receptor for advanced glycation end‐products and mortality in colorectal cancer patients

  2024cites this paper
• The RAGE Inhibitor TTP488 (Azeliragon) Demonstrates Anti-Tumor Activity and Enhances the Efficacy of Radiation Therapy in Pancreatic Cancer Cell Lines

  2024cites this paper
• S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway.

  2024cites this paper
• The role of surgical tissue injury and intraoperative sympathetic activation in postoperative immunosuppression after breast-conserving surgery versus mastectomy: a prospective observational study

  2024cites this paper
• RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancer

  2023cites this paper
• The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential

  2023cites this paper
• Recent Advancement in the Inhibition of Triple-negative Breast Cancer by N-Heterocycles.

  2023cites this paper
• The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells

  2023cites this paper
• RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review

  2022cites this paper
• AllergoOncology: Role of immune cells and immune proteins

  2022cites this paper
• S100P contributes to promoter demethylation and transcriptional activation of SLC2A5 to promote metastasis in colorectal cancer

  2021cites this paper
• Design, synthesis and anti-TNBC activity of Azeliragon triazole analogues.

  2021cites this paper
• A New Hybrid Protein Is a Novel Regulator for Experimental Colitis in Rats

  2021cites this paper
• Perspectives on signaling for biological- and processed food-related advanced glycation end-products and its role in cancer progression

  2020influential citation
• OTT_A_240378 2385..2397

  2020cites this paper
• Soluble Receptor for Advanced Glycation End-products (sRAGE) and Colorectal Cancer Risk: A Case–Control Study Nested within a European Prospective Cohort

  2020cites this paper
• Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of Copd.

  2020cites this paper
• SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment.

  2020cites this paper
• RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer

  2020cites this paper
• Downregulation of RAGE Inhibits Cell Proliferation and Induces Apoptosis via Regulation of PI3K/AKT Pathway in Cervical Squamous Cell Carcinoma

  2020cites this paper
• Prognostic values of S100 family mRNA expression in ovarian cancer

  2019cites this paper
• S100A2 induces the growth of Calu-6 Lung Cancer Cells via apoptosis inhibition, invasion enhancement and promoting cell division

  2019cites this paper
• Clinical Implications of Extracellular HMGA1 in Breast Cancer

  2019cites this paper
• RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies

  2018cites this paper
• S100 can be used as a tumor marker in canine mammary tumors

  2018cites this paper
• Targeting RAGE Signaling in Inflammatory Disease.

  2018cites this paper
• Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis

  2017cites this paper
• All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.

  2017cites this paper
• Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma

  2017cites this paper
• Evaluation of functional RAGE gene polymorphisms in childhood acute lymphoblastic leukemia—A case-control study from Iran

  2017cites this paper
• Targeting RAGE Expression in Human Ovarian Cancer

  2016cites this paper
• HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets.

  2016cites this paper
• Design, Synthesis and Biological Evaluation of Potential Inhibitors of S100P, a Protein implicated in Pancreatic Cancer

  2016cites this paper
• USEFUL MELANOMA DIAGNOSTIC TOOLS: IMMUNOHISTOCHEMISTRY AND MOLECULAR TECHNIQUES. TESTE UTILE IN DIAGNOSTICUL MELANOMULUI: TEHNICI IMUNOHISTOCHIMICE SI MOLECULARE

  2016cites this paper
• Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast

  2016cites this paper
• Pentamidine blocks the interaction between mutant S100A5 and RAGE V domain and inhibits the RAGE signaling pathway.

  2016cites this paper
• Toll-like receptor 2 (TLR2) is a marker of angiogenesis in the necrotic area of human medulloblastoma.

  2015cites this paper
• High-Throughput Screening for Biomarker Discovery

  2015cites this paper
• Expression of the receptor for advanced glycation end-products and frequency of polymorphism in lung cancer.

  2015cites this paper
• RAGE and Its Ligands in Melanoma

  2015cites this paper
• Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion

  2015cites this paper
• RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells

  2015cites this paper
• Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma

  2015cites this paper
• S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.

  2014cites this paper
• Measurement of urinary canine S100A8/A9 and S100A12 concentrations as candidate biomarkers of lower urinary tract neoplasia in dogs

  2014cites this paper
• The receptor for advanced glycation end products influences the expression of its S100 protein ligands in melanoma tumors.

  2014cites this paper
• Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update.

  2014cites this paper
• Psoriasin For Better or for Worse in Sickness and in Health : The Role of Psoriasin in Angiogenesis and Differentation of Epithelial Cells

  2014cites this paper
• Receptor for Advanced Glycation End Products (RAGE) and Its Ligands: Focus on Spinal Cord Injury

  2014cites this paper
• Rage (Receptor for Advanced Glycation End Products) in Melanoma Progression

  2014cites this paper
• PSORIASIN FOR BETTER OR FOR WORSE IN SICKNESS AND IN HEALTH THE ROLE OF PSORIASIN IN ANGIOGENESIS AND DIFFERENTIATION OF EPITHELIAL CELLS

  2014cites this paper
• Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3.

  2014cites this paper
• RAGE overexpression confers a metastatic phenotype to the WM115 human primary melanoma cell line.

  2014cites this paper
• Biomarkers As Indicators Of Severity Of Cerebral Damage In Postoperative Brain Tumor Patients

  2013cites this paper
• Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer

  2013influential citation
• Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology

  2013cites this paper
• Specific siRNA Targeting Receptor for Advanced Glycation End Products (RAGE) Decreases Proliferation in Human Breast Cancer Cell Lines

  2013cites this paper
• S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/β-Catenin Pathway

  2013cites this paper
• Alternative Splicing of the RAGE Cytoplasmic Domain Regulates Cell Signaling and Function

  2013cites this paper
• Low molecular weight heparin suppresses receptor for advanced glycation end products‐mediated expression of malignant phenotype in human fibrosarcoma cells

  2013cites this paper
• Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation

  2012cites this paper
• Effect of breast cancer adjuvant therapies on potential biomarkers of pulmonary inflammation.

  2012cites this paper
• Genotyping of –374A/T, –429A/G, And 63 bp Ins/Del Polymorphisms of Rage By Rapid One-Step Hexaprimer Amplification Refractory Mutation System Polymerase Chain Reaction in Breast Cancer Patients

  2012cites this paper
• Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma

  2012cites this paper
• The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma

  2012cites this paper
• A CXCL1 paracrine network links cancer chemoresistance and metastasis.

  2012cites this paper
• Expression and purification of bioactive high-purity human S100A6 in Escherichia coli.

  2012cites this paper
• -Till min kära familj

  2012cites this paper
• Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation

  2012cites this paper
• Targeting receptor for advanced glycation end products (RAGE) expression induces apoptosis and inhibits prostate tumor growth.

  2012cites this paper
• The Roles of S100 Proteins and RAGE in Melanoma

  2011cites this paper
• Calcium-binding protein S100P and cancer: mechanisms and clinical relevance

  2011cites this paper
• Búsqueda de biomarcadores de enfermedad en lupus eritematoso sistémico por técnicas de inmunología celular y proteómica

  2011cites this paper
• Proteomic analysis of urinary upper gastrointestinal cancer markers

  2011cites this paper
• Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B.

  2011cites this paper
• HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation

  2011cites this paper
• Transcriptional regulation and functional implication of S100P in cancer

  2011influential citation
• Low-Anticoagulant Heparins in the Treatment of Metastasis

  2011cites this paper
• The Receptor for Advanced Glycation End Products (RAGE) and the Lung

  2010cites this paper
• Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling.

  2010cites this paper
• Tissue Microarray Applications in Drug Discovery for Pancreatic Cancer

  2010cites this paper
• High-mobility group B1 (HMGB1) and receptor for advanced glycation end-products (RAGE) expression in canine lymphoma.

  2010cites this paper
• mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer

  2010cites this paper
• Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis.

  2010cites this paper
• Large-scale proteomic identification of S100 proteins in breast cancer tissues

  2010cites this paper
• Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo.

  2010cites this paper
• RAGE: a multi-ligand receptor unveiling novel insights in health and disease.

  2010cites this paper
• Identification and characterization of novel ERC‐55 interacting proteins: Evidence for the existence of several ERC‐55 splicing variants; including the cytosolic ERC‐55‐C

  2009cites this paper
• S100A2 Induces Metastasis in Non–Small Cell Lung Cancer

  2009cites this paper
• Quantification of Dendritic Cells and Osteoclasts in the Bone Marrow of Patients with Monoclonal Gammopathy

  2009cites this paper
• Up-regulation of RAGE and S100A6 in rats exposed to cigarette smoke.

  2009cites this paper
• Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

  2009cites this paper
• Expression and purification of bioactive high-purity human midkine in Escherichia coli

  2009cites this paper
• Proteomic Analysis of Lung Tissue of Rats Exposed to Cigarette Smoke and Radon

  2009cites this paper
• Structure of the S100A6 complex with a fragment from the C-terminal domain of Siah-1 interacting protein: a novel mode for S100 protein target recognition.

  2008cites this paper
• S100 protein family and its application in clinical practice.

  2008cites this paper